• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial.

作者信息

Hallstrom A, Pratt C M, Greene H L, Huther M, Gottlieb S, DeMaria A, Young J B

机构信息

Clinical Trial Center, University of Washington, Seattle 98105, USA.

出版信息

J Am Coll Cardiol. 1995 May;25(6):1250-7. doi: 10.1016/0735-1097(94)00553-3.

DOI:10.1016/0735-1097(94)00553-3
PMID:7722117
Abstract

OBJECTIVES

We studied the relations between heart failure, ejection fraction, arrhythmia suppression and mortality.

BACKGROUND

Both left ventricular ejection fraction and functional class of heart failure are strongly associated with mortality after acute myocardial infarction. Both are also related to the presence of ventricular arrhythmias and have been identified as factors related to the ability to suppress ventricular arrhythmias. Little has been reported about the relations between these two factors and arrhythmia suppression or mortality.

METHODS

Baseline data from the Cardiac Arrhythmia Suppression Trial were used to define several categories of heart failure and to relate both the resulting categories and ejection fraction to arrhythmia suppression and mortality using logistic and survival regression analytic methodologies.

RESULTS

Regardless of the prospective baseline definition of heart failure used, the data consistently showed that heart failure was a more powerful predictor of subsequent congestive heart failure events and arrhythmia suppression and was equally powerful in predicting death. However, each variable provided incremental information when included in the prediction model. Heart failure and ejection fraction appeared to be independent predictors of death. Interactions were observed: A low ejection fraction was more predictive of failure of arrhythmia suppression in patients with than without evidence of heart failure before or at baseline; a low ejection fraction was more predictive of subsequent congestive heart failure events in patients without than with evidence of heart failure before or at baseline.

CONCLUSIONS

Although heart failure as a prognostic feature appears to be somewhat superior to ejection fraction, both are powerful predictors of arrhythmia suppression and cardiac events in patients with ventricular arrhythmia after myocardial infarction. Each provides incremental prediction.

摘要

相似文献

1
Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial.
J Am Coll Cardiol. 1995 May;25(6):1250-7. doi: 10.1016/0735-1097(94)00553-3.
2
Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.恩卡胺、氟卡胺、丙咪嗪和莫雷西嗪对急性心肌梗死后一年内室性心律失常的影响:CAPS研究
Am J Cardiol. 1988 Mar 1;61(8):501-9. doi: 10.1016/0002-9149(88)90754-0.
3
Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).心肌梗死患者的基线特征与恩卡尼、氟卡尼和莫雷西嗪治疗风险的相互作用。心律失常抑制试验(CAST)中死亡率增加的一种可能解释。
Circulation. 1994 Dec;90(6):2843-52. doi: 10.1161/01.cir.90.6.2843.
4
Events in the cardiac arrhythmia suppression trial: baseline predictors of mortality in placebo-treated patients.心脏心律失常抑制试验中的事件:安慰剂治疗患者死亡率的基线预测因素。
J Am Coll Cardiol. 1991 Nov 15;18(6):1434-8. doi: 10.1016/0735-1097(91)90671-u.
5
Effects of advancing age on the efficacy and side effects of antiarrhythmic drugs in post-myocardial infarction patients with ventricular arrhythmias. The CAST Investigators.
J Am Geriatr Soc. 1992 Jul;40(7):666-72. doi: 10.1111/j.1532-5415.1992.tb01957.x.
6
Late ventricular potentials in risk assessment of the occurrence of complex ventricular arrhythmia in patients with myocardial infarction and heart failure.晚期心室电位在心肌梗死和心力衰竭患者复杂室性心律失常发生风险评估中的应用
Vojnosanit Pregl. 2004 Nov-Dec;61(6):589-97. doi: 10.2298/vsp0406589c.
7
Time to arrhythmic, ischemic, and heart failure events: exploratory analyses to elucidate mechanisms of adverse drug effects in the Cardiac Arrhythmia Suppression Trial.发生心律失常、缺血及心力衰竭事件的时间:心脏心律失常抑制试验中阐明药物不良反应机制的探索性分析
Am Heart J. 1995 Jul;130(1):71-9. doi: 10.1016/0002-8703(95)90238-4.
8
Recruitment and baseline description of patients in the Cardiac Arrhythmia Pilot Study. The Cardiac Arrhythmia Pilot Study (CAPS) investigators.心律失常初步研究中患者的招募与基线描述。心律失常初步研究(CAPS)研究者们。
Am J Cardiol. 1988 Apr 1;61(10):704-13. doi: 10.1016/0002-9149(88)91052-1.
9
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.接受恩卡尼、氟卡尼或安慰剂治疗患者的死亡率和发病率。心律失常抑制试验。
N Engl J Med. 1991 Mar 21;324(12):781-8. doi: 10.1056/NEJM199103213241201.
10
Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. The Cardiac Arrhythmia Suppression Trial/Signal-Averaged Electrocardiogram (CAST/SAECG) Substudy Investigators.心肌梗死后严重心律失常事件的时域信号平均心电图最佳预测标准的定义。心脏心律失常抑制试验/信号平均心电图(CAST/SAECG)子研究调查人员。
J Am Coll Cardiol. 1995 Mar 15;25(4):908-14. doi: 10.1016/0735-1097(94)00504-j.

引用本文的文献

1
Sacubitril/valsartan and arrhythmic burden in patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis.沙库巴曲缬沙坦与射血分数降低的心力衰竭患者的心律失常负担:一项系统评价和荟萃分析。
Heart Fail Rev. 2023 Nov;28(6):1395-1403. doi: 10.1007/s10741-023-10326-1. Epub 2023 Jun 29.
2
Effect of Sacubitril/Valsartan on Reducing the Risk of Arrhythmia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.沙库巴曲缬沙坦对降低心律失常风险的影响:一项随机对照试验的系统评价和荟萃分析
Front Cardiovasc Med. 2022 Jul 1;9:890481. doi: 10.3389/fcvm.2022.890481. eCollection 2022.
3
Is Low Heart Rate Variability Associated with Emotional Dysregulation, Psychopathological Dimensions, and Prefrontal Dysfunctions? An Integrative View.
低心率变异性是否与情绪失调、精神病理学维度及前额叶功能障碍相关?一种综合观点。
J Pers Med. 2021 Aug 31;11(9):872. doi: 10.3390/jpm11090872.
4
Value of Cardiovascular Magnetic Resonance Imaging-Derived Baseline Left Ventricular Ejection Fraction and Volumes for Precise Risk Stratification of Patients With Ischemic Cardiomyopathy: Insights From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial.基于心血管磁共振成像的左心室射血分数和容积基线值对缺血性心肌病患者进行精确危险分层的价值:来自缺血性心力衰竭的外科治疗(STICH)试验的见解。
JAMA Cardiol. 2017 May 1;2(5):577-579. doi: 10.1001/jamacardio.2016.5492.
5
Personalized Computer Simulation of Diastolic Function in Heart Failure.心力衰竭舒张功能的个性化计算机模拟
Genomics Proteomics Bioinformatics. 2016 Aug;14(4):244-52. doi: 10.1016/j.gpb.2016.04.006. Epub 2016 Jul 29.
6
Quantitative evaluation of the amount of delayed myocardial enhancement as a predictor of systolic dysfunction.作为收缩功能障碍预测指标的延迟心肌强化量的定量评估。
Open Cardiovasc Med J. 2009 May 18;3:35-8. doi: 10.2174/1874192400903010035.
7
Development of more erratic heart rate patterns is associated with mortality post-myocardial infarction.心率模式愈发不稳定与心肌梗死后的死亡率相关。
J Electrocardiol. 2008 Mar-Apr;41(2):110-5. doi: 10.1016/j.jelectrocard.2007.11.005.
8
Prevalence and incidence of arrhythmias and sudden death in heart failure.心力衰竭中心律失常和猝死的患病率与发病率
Heart Fail Rev. 2002 Jul;7(3):229-42. doi: 10.1023/a:1020024122726.
9
Predicting the recurrence of ventricular tachyarrhythmias from T-wave alternans assessed on antiarrhythmic pharmacotherapy: a prospective study in patients with dilated cardiomyopathy.基于抗心律失常药物治疗评估的T波电交替预测扩张型心肌病患者室性快速性心律失常复发:一项前瞻性研究
Ann Noninvasive Electrocardiol. 2001 Jul;6(3):203-8. doi: 10.1111/j.1542-474x.2001.tb00109.x.
10
Clinical and demographic determinants of heart rate variability in patients post myocardial infarction: insights from the cardiac arrhythmia suppression trial (CAST).心肌梗死后患者心率变异性的临床和人口统计学决定因素:来自心律失常抑制试验(CAST)的见解。
Clin Cardiol. 2000 Mar;23(3):187-94. doi: 10.1002/clc.4960230311.